 Connection
Lisa Maier to HLA-DR Antigens
This is a "connection" page, showing publications Lisa Maier has written about HLA-DR Antigens.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.292 |
|
|
|
-
Li L, Hamzeh N, Gillespie M, Elliott J, Wang J, Gottschall EB, Mroz PM, Maier LA. Beryllium increases the CD14(dim)CD16+ subset in the lung of chronic beryllium disease. PLoS One. 2015; 10(2):e0117276.
Score: 0.107
-
Sato H, Woodhead FA, Ahmad T, Grutters JC, Spagnolo P, van den Bosch JM, Maier LA, Newman LS, Nagai S, Izumi T, Wells AU, du Bois RM, Welsh KI. Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups. Hum Mol Genet. 2010 Oct 15; 19(20):4100-11.
Score: 0.078
-
Bill JR, Mack DG, Falta MT, Maier LA, Sullivan AK, Joslin FG, Martin AK, Freed BM, Kotzin BL, Fontenot AP. Beryllium presentation to CD4+ T cells is dependent on a single amino acid residue of the MHC class II beta-chain. J Immunol. 2005 Nov 15; 175(10):7029-37.
Score: 0.056
-
Maier LA, McGrath DS, Sato H, Lympany P, Welsh K, Du Bois R, Silveira L, Fontenot AP, Sawyer RT, Wilcox E, Newman LS. Influence of MHC class II in susceptibility to beryllium sensitization and chronic beryllium disease. J Immunol. 2003 Dec 15; 171(12):6910-8.
Score: 0.049
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|